INKT (STOCKS)
MiNK Therapeutics, Inc. Common Stock
$12.535000
+0.515000 (+4.28%)
Prev close: $12.020000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Jennifer S. Buell
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $63.37M
- Employees
- 23
- P/E (TTM)
- -4.23
- P/B (TTM)
- -4.71
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.57 | $-0.79 | +0.2154 | +27.43% |
|
Dec 2025 (Q4)
|
$-0.56 | $-0.84 | +0.2814 | +33.64% |
|
Sep 2025 (Q3)
|
$-0.65 | $-0.87 | +0.2221 | +25.47% |
|
Jun 2025 (Q2)
|
$-1.06 | $-0.56 | -0.5024 | -90.10% |
Financial Statements
| Revenues | $247.56K |
| Benefits Costs and Expenses | $5.54M |
| Costs And Expenses | $12.83M |
| Operating Expenses | $13.07M |
| Research and Development | $5.70M |
| Other Operating Expenses | $7.37M |
| Operating Income/Loss | -$12.82M |
| Income/Loss From Continuing Operations After Tax | -$12.47M |
| Income/Loss From Continuing Operations Before Tax | -$9.53M |
| Interest And Dividend Income, Operating | $162.56K |
| Interest Expense, Operating | -$85.00K |
| Interest Income/Expense After Provision For Losses | $247.56K |
| Interest Income/Expense Operating, Net | $247.56K |
| Net Income/Loss | -$12.47M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$12.47M |
| Net Income/Loss Available To Common Stockholders, Basic | -$12.47M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Provision For Loan, Lease, And Other Losses | $0.00 |
| Basic Earnings Per Share | -$2.82 |
| Diluted Earnings Per Share | -$2.82 |
| Basic Average Shares | 13,361,726 |
| Diluted Average Shares | 13,361,726 |
| Assets | $10.38M |
| Current Assets | $10.02M |
| Prepaid Expenses | $264.52K |
| Other Current Assets | $9.76M |
| Noncurrent Assets | $354.52K |
| Fixed Assets | $354.52K |
| Liabilities | $23.06M |
| Current Liabilities | $7.29M |
| Accounts Payable | $3.39M |
| Other Current Liabilities | $3.90M |
| Noncurrent Liabilities | $15.78M |
| Equity | -$12.69M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$12.69M |
| Liabilities And Equity | $10.38M |
| Net Cash Flow From Operating Activities | -$6.32M |
| Net Cash Flow From Operating Activities, Continuing | -$6.32M |
| Net Cash Flow From Investing Activities | -$6.29M |
| Net Cash Flow From Investing Activities, Continuing | -$6.30M |
| Net Cash Flow From Financing Activities | $12.62M |
| Net Cash Flow From Financing Activities, Continuing | $12.62M |
| Exchange Gains/Losses | -$12.83K |
| Net Cash Flow | $12.83K |
| Net Cash Flow, Continuing | $25.65K |
| Comprehensive Income/Loss | -$12.50M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$12.50M |
| Other Comprehensive Income/Loss | -$34.99K |